Oy. More Red Sox steroid stuff. Take it, Boston Globe:
Major League Baseball opened an
investigation into performance-enhancing drugs inside the Red Sox
clubhouse at the height of last year’s pennant race after two members
of the team’s security staff were implicated in steroid use.
security staffers said they were dismissed after what they termed a
cursory inquiry by Major League Baseball, and very limited questioning
by the team – even though one of the guards says he swapped advice
about steroids with David Ortiz’s close friend and personal assistant.
The men in question are Nicholas Alex Cyr, 27, and Jared Remy,
30, son of Red Sox broadcaster Jerry Remy. The league began an
investigation after a vial of steroids was confiscated from Cyr’s car
last July. Cyr claimed that he bought the steroids from Remy. Both men
say they have no direct knowledge of steroid use by Red Sox players,
including David Ortiz and Manny Ramirez, whose names were leaked from
the infamous 2003 doping list by the New York Times this week.
That said, Remy didn’t find the team’s investigation all that thorough:
sure they were hoping I didn’t know anything. It’s like they didn’t
want to know. It’s like: Do we really want to know or do we just want
it to go away?”
Just because these two losers used steroids doesn’t necessarily mean
anything, but the fact that they had such close access to the players,
including running errands in Ramirez’s car, should be alarming.
The Giants have acquired infielder Gordon Beckham from the Braves in exchange for cash considerations, David O’Brien of the Atlanta Journal-Constitution reports.
Eduardo Nunez injured his hamstring on Sunday, leaving the Giants with another hole to fill at third base. Beckham isn’t eligible for inclusion on the Giants’ postseason roster.
Beckham, 30, hit .217/.300/.354 with five home runs and 30 RBI in 273 plate appearances with the Braves. He spent most of his time at second base but also spent some time at third base and shortstop. Beckham has nearly 1,500 career innings at third base, so moving back to the hot corner shouldn’t be a big deal.
Mets GM Sandy Alderson addressed the media about the status of starter Steven Matz on Tuesday afternoon. Alderson said that Matz will undergo “imminent” elbow surgery to address a bone spur in the lefty’s elbow, Marc Carig of Newsday reports. That will end Matz’s season.
Matz was expected to return this past Friday, but was scratched due to shoulder soreness. According to Carig, the shoulder doesn’t appear to be a major issue.
Matz, 25, finishes the season with a 9-8 record, a 3.40 ERA, and a 129/31 K/BB ratio in 132 1/3 innings. It was a pretty good showing for his first full season in the majors.
The Mets enter Tuesday’s action a half-game up on the Giants for the first of two National League Wild Card slots. If the Mets can secure one of those slots and then advance to the NLDS, they will likely use a rotation that includes Noah Syndergaard, Bartolo Colon, Seth Lugo, and Robert Gsellman.